$93.1-106.4k
+ Employee Stock Purchase Plan
More information about location
Healthcare solutions rooted in advocacy
Job no longer available
Healthcare solutions rooted in advocacy
1001+ employees
Job no longer available
$93.1-106.4k
+ Employee Stock Purchase Plan
More information about location
1001+ employees
To be the first place people go to find answers, take action, and get care in the moments that matter.
Jump to section
To be the first place people go to find answers, take action, and get care in the moments that matter.
Accessing healthcare can be a time-consuming and frustrating process. Telehealth company Accolade is here to combat this problem with a platform to access benefits, care, and trusted guidance in a seamless and speedy way.
The company, founded in 2020, is one of a number hoping to revolutionize the way healthcare is accessed. Its approach is to bring together everything patients need under one roof, making it more connected and hence easier to understand and act on.
Accolade has grown steadily over the years, acquiring fellow telemedicine solution PlushCare along the way. It was itself acquired by Transcarent in 2025, merging to form a combined entity that serves millions of members and hundreds of organizations.

Freddie
Company Specialist at Welcome to the Jungle
Jun 2020
$23m
SERIES B
Nov 2016
$8m
SERIES A
This company has top investors
Glen Tullman
(CEO (Transcarent))CEO of the parent company of Accolade. Former CEO at Enterprise Systems, Allscripts and Livongo. Founded and was Managing Partner at 7wireVentures for 7 years.